Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Schrödinger, Inc.NASDAQ: SDGR

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q3 FY2026 weighted avg shares (diluted) of 74.87M shares rose 1.7% year over year, in line with the +1.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.2% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +1.7% toward the trailing-twelve-month pace of +1.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
74.87M-1.2% QoQ
Last fiscal yearDec 2025
73.44M+1.1% YoY
LTMSep 2026
74.52M+1.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.7%——
1 year+1.1%——
3-year CAGR+1.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
73.44M USD
Year-over-year change
+1.1%
4-year CAGR
+1.0%

Weighted Avg Shares (Diluted) vs competitors

How SDGR compares with its peers on the latest reported figures

  • SDGR's LTM Sep 2026 weighted avg shares (diluted) of 74.52M shares is the 5th highest of the 9 companies compared; the peer median is 105M shares.
  • Its year-over-year change of +1.8% is the 4th highest of 9, against a peer median of +1.0%.
  • Over three fiscal years its annual growth of +1.1% compares with a peer median of +0.2%.
SDGR Competitors Peer median
Weighted Avg Shares (Diluted) for SDGR and competitors
Company Period LTM YoY 3-year CAGR
ABCLAbCellera Biologics Inc.LTM Sep 2026306.35M +3.0%-1.7%
RLAYRelay Therapeutics, Inc.LTM Jun 2026181.67M +12.1%+15.2%
VEEVVeeva Systems Inc.LTM Jul 2026166.82M +0.5%+0.9%
CERTCertara, Inc.LTM Mar 2026159.92M -0.6%+0.2%
SDGRSchrödinger, Inc.LTM Sep 202674.52M +1.8%+1.1%
GENBGenerate Biomedicines, Inc.FY202550.09M -60.7%—
HYFTMindWalk Holdings Corp.LTM Jan 202641.36M +43.8%+19.2%
SLPSimulations Plus, Inc.LTM Feb 202620.18M -0.4%-1.1%
LTRNLantern Pharma Inc.LTM Mar 202610.94M +1.6%+0.1%
Peer median (excluding SDGR) 105M+1.0%+0.2%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue137.93M180.96M216.67M207.54M255.87M
Cost of Revenue72.31M79.93M75.97M75.46M113.26M
Gross Profit65.62M101.02M140.69M132.08M142.61M
Gross Margin47.6%55.8%64.9%63.6%55.7%
Research & Development90.9M126.37M181.77M201.79M173.14M
Selling, General & Admin86.16M121.47M136.37M139.59M136.37M
Operating Expenses177.06M247.84M318.14M341.38M309.51M
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
EBITDA(97.96M)(144.78M)48.47M(179.55M)(96.3M)
EBITDA Margin-71.0%-80.0%22.4%-86.5%-37.6%
Operating Income(111.44M)(146.82M)(177.45M)(209.3M)(166.9M)
Operating Margin-80.8%-81.1%-81.9%-100.8%-65.2%
Interest Income1.06M3.95M000
Interest Expense03K000
Other Income / Expenses10.64M(2.31M)220.37M23.59M64.57M
Income Before Tax(100.81M)(149.12M)42.92M(185.71M)(102.33M)
Pre-Tax Margin-73.1%-82.4%19.8%-89.5%-40.0%
Income Tax Expense411K63K2.2M1.41M939K
Net Income(100.39M)(149.19M)40.72M(187.12M)(103.27M)
Net Margin-72.8%-82.4%18.8%-90.2%-40.4%
EPS (Basic)(1.43)(2.10)0.57(2.57)(1.41)
EPS (Diluted)(1.43)(2.10)0.54(2.57)(1.41)
Weighted Avg Shares70.59M71.17M71.78M72.67M73.44M
Weighted Avg Shares (Diluted)70.59M71.17M74.99M72.67M73.44M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.